Tag Archives: IT

top 50 stocks to buy

U.K. stocks swung between small gains and losses on Thursday, but stayed close to a record high as miners continued to march higher on the back of a rally in commodity prices.

What are markets doing: The FTSE 100 index
UKX, +0.10%
was marginally higher at 7,622.45, building on a 0.4% gain from Wednesday that was enough for the benchmark to score an all-time closing high.

top 50 stocks to buy: Embraer-Empresa Brasileira de Aeronautica(ERJ)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Friday, industrials shares fell by 0.12 percent. Meanwhile, top losers in the sector included Stericycle Inc (NASDAQ: SRCL), down 17 percent, and Embraer SA (ADR) (NYSE: ERJ), down 13 percent.

  • [By Paul Ausick]

    Boeing also confirmed on Thursday that it has discussed a “possible combination” with Brazil’s Embraer S.A. (NYSE: ERJ), a response to the deal Bombardier struck with Airbus in which the European company took control of Bombardier’s C Series program. A deal between Boeing and Embraer is no sure thing, mainly because the Brazilian government holds a controlling interest in Embraer.

top 50 stocks to buy: Gartner, Inc.(IT)

Advisors’ Opinion:

  • [By Lisa Levin]

    CEB Inc. (NYSE: CEB) shares were also up, gaining 21 percent to $74.90 after Gartner Inc (NYSE: IT) announced plans to acquire the company for $2.6 billion in cash and stock.

top 50 stocks to buy: Norsat International Inc.(NSAT)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Norsat International Inc (USA) (NYSE: NSAT) got a boost, shooting up 22 percent to $9.85 after the company reported the receipt of new indication of interest by Privet Fund Management LLP at $10.25 per share.

top 50 stocks to buy: Cummins Inc.(CMI)

Advisors’ Opinion:

  • [By Reuben Gregg Brewer]

    Making mining equipment has been a horrible business over the last few years. The industry has been hard-hit by the spending cutbacks at mine sites around the world. For example, BHP Billiton Limited trimmed its capital exploration expenditures by roughly 70% between fiscal 2013 and 2016. No wonder Caterpillar Inc. (NYSE:CAT), Komatsu Ltd. (NASDAQOTH:KMTUY), and Cummins Inc. (NYSE:CMI) have been hurting. Only that looks like it’s starting to change, which means this trio could be at the top of a list of mining equipment companies to buy in 2017.

  • [By Reuben Gregg Brewer]

    Ever walk past a construction site? It’s hard not to be enthralled by all the heavy construction machinery moving things around. With the world’s developing economies still building at a relatively fast pace and developing economies, like the United States, in desperate need of upgrading their aging infrastructure, the companies behind that construction machinery could be just as exciting as a construction site in the years ahead. Which is why Caterpillar Inc. (NYSE:CAT), Cummins Inc. (NYSE:CMI), and Terex Corporation (NYSE:TEX) are three of the top construction machinery stocks to look at right now.

  • [By WWW.THESTREET.COM]

    In the Lightning Round, Cramer was bullish on Salesforce.com (CRM) , Paccar (PCAR) , Cummins (CMI) , ConocoPhillips (COP) , Adobe Systems (ADBE) , Annaly Capital (NLY) and Hewlett Packard Enterprise (HPE) .

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close Friday was Cummins Inc. (NYSE: CMI) which traded down about 5% at $159.44. The stocks 52-week range is $134.06 to $181.79. Volume was over 3.5 million versus the daily average of 1.2 million shares.

  • [By WWW.THESTREET.COM]

    There are lots of stories like that out there these days. People were perplexed about the Illinois Tool Works (ITW) and Cummins Engine (CMI) and Caterpillar (CAT) quarters, but they turned out to be classic buying opportunities after years of being sell opportunities if the stocks had run. I can’t explain to you how amazing that is. Here are three stocks that have spent months and months in purgatory when they have missed or guided down or slashed forecasts. Now they are up gigantically.

top 50 stocks to buy: SPDR Blmbg Barclays Em Mkts Lcl Bd ETF (EBND)

Advisors’ Opinion:

  • [By Todd Shriber, ETF Professor]

    DWFI also holds the SPDR Barclays Emerging Markets Local Bond ETF (NYSE: EBND), SPDR Barclays International Treasury Bond ETF (NYSE: BWX) and the SPDR Barclays Intermediate Term Corporate Bond ETF (NYSE: ITR).

Best Blue Chip Stocks To Watch For 2018

"Short Sellers Retreat Amid Rally," ran the headline in the Wall Street Journal.   Curious readers stopped and stared. It was the premise of the headline that arrested them. Who knew that there was even one bear left to give ground at the 100-month mark of the post-2008 levitation?   El toro is the topic at hand. It's a most unusual bull market (we count as one the updrafts in stocks and bonds). An unzestful, low-volume, and low-volatility affair, it seems to belong on a psychiatrist's couch. We write to catalogue its singularities with the purpose of addressing the always pertinent question: What to do with money besides enjoy it?   No. 1 is the zest deficit. Since the S&P 500 Index bottomed at an intraday low of 666.79 on March 6, 2009, the blue chips have appreciated by 271%. The country has grown, too, although – famously – the economic expansion leaves much to be desired. Trailing 12-month earnings for the S&P 500 peaked in the third quarter of 2014, and disappointments abound in the data that purport to measure growth in GDP and productivity.

Best Blue Chip Stocks To Watch For 2018: Mitcham Industries Inc.(MIND)

Advisors’ Opinion:

  • [By Monica Gerson]

    Mitcham Industries, Inc. (NASDAQ: MIND) is projected to post a quarterly loss at $0.36 per share on revenue of $10.99 million.

    Sinovac Biotech Ltd. (NASDAQ: SVA) is expected to post its quarterly earnings.

Best Blue Chip Stocks To Watch For 2018: LINE Corporation (LN)

Advisors’ Opinion:

  • [By Wayne Duggan]

    In addition to DianDianChong, Japanese company Line Corp (ADR) (NYSE: LN) holds a nearly 50 percent stake in a South Korean Snapchat clone called Snow. Line’s recent $45 million investment in Snow values the company at around $207 million compared to Snap’s $24.8 billion market cap. Snow currently has 40 million–50 million active users, less than a third of Snapchat’s audience. Snow’s app also features familiar face filters and disappearing messages.

  • [By Seth McNew]

    Shares of the Japanese messaging and increasingly social media-like company Line Corp.(NYSE:LN)took a hit today, falling nearly 12% at one point today, even though the company reported a strong rise in sales for its first quarter and positive results from its new features.

Best Blue Chip Stocks To Watch For 2018: Gartner, Inc.(IT)

Advisors’ Opinion:

  • [By Lisa Levin]

    CEB Inc. (NYSE: CEB) shares were also up, gaining 21 percent to $74.90 after Gartner Inc (NYSE: IT) announced plans to acquire the company for $2.6 billion in cash and stock.

great stock picks

MannKind (NASDAQ:MNKD) investors have had an interesting week. The company announced that Mike Castagna would be the new CEO, and followed that news with an announcement of a deal to move forward on possible Afrezza sales in Brazil. Today the company announced that it has engaged a strategic partner to explore possible deals surrounding its Technosphere technology. Locust Walk will seek possible partnerships for Technosphere in an effort to raise needed capital. With three waves of news, script sales likely took a back seat for the moment, but as savvy investors are aware, the main revenue stream of the company is U.S. sales of Afrezza.

This week, scripts came in at about 270 with new scripts and refills taking a dip. MannKind has struggled to get above 300 scripts per week and maintain growth. Since the company took over the marketing of the inhaled insulin it has only seen script levels above 300 twice. For the better part of a year now scripts have essentially been treading water. What is needed is meaningful and consistent growth. Sales need to be several times higher than what they currently are for the street to appreciate that Afrezza has a shot in a highly competitive diabetes space. Eleven months ago when MannKind took full control over marketing, script sales were at 266. This past week, sales were at 269. MannKind will point out that the number of cartridges is now higher, but that is a very small consolation to the flatness of the sales trajectory.

great stock picks: Host Hotels & Resorts, Inc.(HST)

Advisors’ Opinion:

  • [By Dividends4Life]

    Host Hotels & Resorts Inc. (HST) is a publicly owned real estate investment trust (REIT). The firm primarily engages in the ownership and operation of hotel properties. Sept. 16, the company increased its quarterly dividend 9.1% to $0.12 per share. The dividend is payable on Oct. 15, 2013, to stockholders of record on Sept. 30, 2013. The yield based on the new payout is 2.6%.

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Thursday was Host Hotels & Resorts, Inc. (NYSE: HST) which rose nearly 4% to $19.40. The stocks 52-week range is $14.69 to $20.21. Volume was 16.3 million compared to its average volume of 6.1 million.

  • [By Michael Flannelly]

    Host Hotels and Resorts Inc (HST) announced early on Monday that it is raising its quarterly dividend payout from 11 cents per share to 12 cents per share, a 9.1% increase.

    This quarterly dividend payout will be paid on October 15 to shareholders of record on September 30, with an ex-dividend date of September 26.

    Host Hotels shares were inactive during pre-market trading on Monday. The stock is up 15.25% year-to-date.

great stock picks: Viking Therapeutics, Inc.(VKTX)

Advisors’ Opinion:

  • [By Lisa Levin]

     

    Losers
    DBV Technologies SA – ADR (NASDAQ: DBVT) shares tumbled 50.6 percent to $23.73 after the company disclosed that its peanut allergy trial failed to meet primary endpoint.
    Connecture Inc (NASDAQ: CNXR) shares declined 40.8 percent to $0.290. Connecture reported that it will voluntarily delist from the NASDAQ for OTCQX Market.
    Walter Investment Management Corp (NYSE: WAC) slipped 19.2 percent to $0.410. On Friday, Walter Investment Management disclosed that it has reached an agreement with term lenders and senior noteholders on financial restructuring.
    Eldorado Gold Corp (USA) (NYSE: EGO) shares dropped 15.9 percent to $1.83. Eldorado Gold lowered its production guidance for its Kisladag operation.
    Seanergy Maritime Holdings Corp. (NASDAQ: SHIP) shares fell 15.4 percent to $1.04.
    Future Fintech Group Inc (NASDAQ: FTFT) dropped 13.6 percent to $1.53. Future FinTech reported filing of proxy statement, including proposal for corporate restructuring.
    Concordia International Corp (NASDAQ: CXRX) shares fell 12.3 percent to $0.500 after dipping 38.71 percent on Friday.
    Aemetis Inc (NASDAQ: AMTX) shares declined 11.3 percent to $0.550
    OncoSec Medical Inc (NASDAQ: ONCS) dipped 10.5 percent to $1.12. OncoSec reported a $7.1 million registered direct at-the-market offering at a price of $1.34375 per share.
    Evoke Pharma Inc (NASDAQ: EVOK) shares fell 10.35 percent to $3.08 after the company disclosed 'positive' topline results from comparative exposure pharmacokinetic study for Gimoti.
    Eiger Biopharmaceuticals Inc (NASDAQ: EIGR) shares dropped 9.4 percent to $11.60 as the company disclosed Phase 2 interim 24-week data with pegylated interferon lambda in Hepatitis Delta Virus infection at the American Association for the Study of Liver Diseases Meeting.
    Viking Therapeutics Inc (NASDAQ: VKTX) shares slipped 6.6 percent to $2.80. Viking Therapeutics presented results from proof-of-concept study of VK0214 in in vivo

  • [By Lisa Levin]

    Viking Therapeutics Inc (NASDAQ: VKTX) shares dropped 39 percent to $1.17 after the company priced 7.5 million share offering at $1.25 per share.

great stock picks: Gartner, Inc.(IT)

Advisors’ Opinion:

  • [By Lisa Levin]

    CEB Inc. (NYSE: CEB) shares were also up, gaining 21 percent to $74.90 after Gartner Inc (NYSE: IT) announced plans to acquire the company for $2.6 billion in cash and stock.

great stock picks: Callidus Software, Inc.(CALD)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Monday, technology shares fell 0.14 percent. Meanwhile, top losers in the sector included Sequans Communications SA ADR (NYSE: SQNS), down 8 percent, and Callidus Software Inc. (NASDAQ: CALD), down 6 percent.

great stock picks: CST Brands, Inc.(CST)

Advisors’ Opinion:

  • [By Monica Gerson]

    CST Brands Inc (NYSE: CST) is projected to report its quarterly earnings at $0.22 per share on revenue of $2.30 billion.

    American Axle & Manufact. Holdings, Inc. (NYSE: AXL) is expected to report its quarterly earnings at $0.71 per share on revenue of $998.76 million.

  • [By Monica Gerson]

    CST Brands Inc (NYSE: CST) is projected to report its quarterly earnings at $0.22 per share on revenue of $2.30 billion. CST Brands shares declined 1.20 percent to close at $36.21 on Thursday.

VMware: Stay Long

VMware (NYSE:VMW), the company best known for its invention of so-called “virtual machines,” or the ability to use software to allocate operating system resources from a remote server to a third-party client, deserves a lot more love than it’s getting, in my opinion. The company posted a solid Q3 underlined by fantastic billings, a top-line beat, and a deluge of free cash flows. Still, despite the good news, VMware’s stock practically stayed flat after the earnings announcement.

It’s been a tough week for the technology sector. The NASDAQ suffered a sharp reversal on the second-to-last trading day of November as tech stocks sold off and investors piled into beaten-down value names in the retail sector. The beginnings of a trend are clear: as we head into 2018 and the S&P 500 continues to shatter records daily (the most recent rally being fueled by supportive Fed commentary), value stocks (and stock selection itself) are top-of-mind topics.

VMware has proven itself as a unique value play – not words commonly used to describe a stock trading at ~24x P/E (though as I mention in a prior article, VMware generates much more free cash flow than GAAP earnings, and its free cash flow valuation is more in line with a cheap 18x multiple – a bargain, especially after this quarter’s cash flow results). Like industrial value names, VMware is a company that’s had to reinvent itself. Back when cloud computing was just a research project, VMware reigned king as client-server computing was the bedrock of enterprise IT, with each company maintaining its own servers and using VMware’s vSphere hypervisor to partition computing resources to “thin clients” – a fancy name for the desktop terminals that fill office desks, but with no computing guts themselves. These days, however, more and more workloads are being shifted to the public cloud, primarily into Amazon’s AWS (NASDAQ:AMZN), and out of corporate-owned “on-premise” data centers.

But to keep itself from becoming irrelevant, VMware has initiated a partnership with AWS to offer VMware Cloud on AWS, which eases the burden on CIOs who want to retain their existing VMware infrastructure while migrating into a public cloud environment. Having rebranded itself as a cloud-friendly vendor that can support “hybrid cloud” environments, VMware is experiencing a renaissance, with revenues growing at double digits for the second sequential quarter – which is fairly uncommon for a large-cap legacy IT company with ~$8 billion in revenues that is dealing with revenue declines in its out-of-vogue products. While Oracle (NYSE:ORCL) isn’t a perfect comp because it’s 4x the size of VMware, Oracle is also a company that is trying to shift from its on-prem legacy to a cloud environment – and Oracle grew only 3% y/y in its last quarter. VMware, by contrast, has really gotten into the swing of things with 21% growth in billings.

The key point to note: VMware is a value name with tremendous valuation support in its free cash flow; but unlike a traditional industrial value play, its new found strength in cloud is supporting double-digit revenue growth and massive (50%-plus) cash flow growth. Tech investors are starting to pay more and more attention to value-oriented growth names, and VMware fits the bill perfectly. The fact that the stock reacted so calmly to a great quarter is indicative of an opportunity to buy. I’ve been long on this name for years, sticking with it through the Dell-EMC tracking stock drama and am retaining a price target of $147 (20x EV/FCF) on the company. Even if (really, when) the company hits that mark sometime in the next year, I’m still holding my shares for the long haul, as VMware’s dominance in the enterprise datacenter (and now its newfound prominence in cloud-based datacenters) merit it a market capitalization in excess of $100 billion (more akin to Oracle and Cisco (NASDAQ:CSCO), other datacenter juggernauts), whereas its valuation now only sits at a polite $49 billion.

Q3 download: remarkable performance across all metrics, especially free cash flow

VMware posted $1.98 billion in revenue (+11% y/y) in Q3, beating out analyst expectations of $1.96 billion. License revenues grew 14% y/y to $785 million, while the remaining bulk of the revenue was derived from maintenance and support services. It’s important to note that this is VMware’s second consecutive quarter of double-digit revenue growth – in Q2, VMware posted 12% growth, while Q1’s growth rate was only 9%. It’s clear that beginning in Q2, VMware began picking up additional steam on the back of its new product offerings.

Figure 1. VMware revenue results
Source: VMware earnings release

As highlighted by the title of this article, however, it’s billings that stole the show (at least in terms of top-line metrics; cash flow growth is VMware’s true prize jewel). As a refresher, like most software companies, VMware’s long-term and subscription deals are booked into deferred revenues and recognized as revenue ratably over time. The sum of revenue plus the change in deferred revenue is referred to as “billings” in the quarter. Billings, rather than revenue, is a clearer picture of the volume of deals closed in a quarter – and in Q3, VMware had a fantastic billings quarter, with total billings of $2.1 billion growing 21% y/, as shown in the chart below:

Figure 2. VMware billings results

Analysts had only called for $2.0 billion in billings (+14% y/y). Given the fact that billings is the longer term yardstick for revenue health and that VMware smashed billings expectations by seven points, I’m surprised that the stock reacted so casually to the billings beat, choosing instead to focus on the thinner beat on revenues.

VMware’s deferred revenue balance grew to $5.6 billion in the quarter ($3.5 billion in short-term and will be recognized as revenue within the year; $2.1 billion is longer term), up 11% y/y. Software maintenance continues to form the bulk of deferred revenues, consisting of the agreements that customers sign with VMware to receive support and software upgrades over a predetermined term.

One more product-related note: VMware also announced that Gartner (NYSE:IT) has proclaimed it the largest software vendor of hyperconverged infrastructure (HCI), based on sales of VMware’s vSAN. Though VMware doesn’t break out sales by product, I must confess that, at least where it concerns HCI, I’m partial to Nutanix (NASDAQ:NTNX) and consider Nutanix the leader of that space. Nutanix, coincidentally, reported earnings on the same day as VMware and blew away analyst expectations, showing at least that there’s room in the field for two. HPE’s SimpliVity (NYSE:HPE), which the crisis-ridden company purchased earlier this year for $650 million, seems to be a very distant third.

Cash flow in focus, supporting VMware’s valuation

Now that we’ve established VMware’s top line metrics are trending strongly, we can turn to the major reason most investors buy VMware: its cash flow.

Cash flow expansion was driven by top-line growth as well as improvements in opex spending; more specifically:

Sales and marketing expenses dropped to 30.7% of revenues, down from 31.7% in 3Q17 General and administrative expenses dropped to 8.9% of revenues, down from 10.0% in 3Q17

VMware improved its operating margin by 2.1% to 23.5% (up from 21.4% in 3Q17). That might sound like a small amount, but at VMware’s revenue scale, two points is more than $40 million – a good chunk to improve earnings by.

Cash flow expanded in tandem. Operating cash flows in the quarter grew 56% y/y to $970 million, and after netting out $59 million of capex, VMware was left with free cash flow of $911 million, up 54% y/y.

Figure 3. VMware free cash flow bridge
This represents a 46% free cash flow margin, among the highest in software and among large-cap companies in general – which proves a salient point about software companies: in the startup phase (or even in a more mature growth phase), software companies might spend a lot on sales and drive massive losses to spur growth, but once they reach VMware’s size, these businesses become cash cows.

In the nine months year to date, VMware has generated $2.2 billion in FCF, representing a 39% margin to YTD revenues of $5.6 billion. Given that in the prior year’s YTD period, VMware generated only $1.8 billion of FCF on revenue of $5.1 billion (a 36% margin), VMware is driving cash flow margins in the right direction.

It’s no secret that VMware is headed in the direction of $10 billion in annual revenues, as its new product initiatives give it access to cloud-based deals that weren’t open to it before. At this scale (which the company should reach in 2-3 years, given its current growth trajectory), VMware would be generating $4 billion in free cash flow annually (assuming its 40% FCF margin holds; in all likelihood, this margin would expand steadily over time).

Compared to VMware’s current $49 billion market cap and $42 billion enterprise value (the company has ~$7 billion in net cash), VMware only trades at a ~10.5x EV/FCF multiple on its hypothetical future cash flow. For the forward-looking investor who believes in VMware’s growth, this cash flow expansion potential makes the stock’s current ~17x FCF multiple (based on FY17 FCF of $2.4 billion) seem like a bargain.

To sense-check VMware’s current valuation against other value yardsticks, the company also trades at a 5.0x EV/FTM revenues multiple (based on a forward-twelve months revenue estimate of $8.2 billion, applying VMware’s growth linearity to its trailing revenues) and 24x P/E, based on analyst consensus FY18 EPS of $5.07 as reported on Yahoo Finance.

Not the cheapest of stocks, but VMware is a software play with the best elements of growth and value.

Stay long on VMware. Very few software stocks are “sleep at night stocks” because so few of them ever reach VMware’s scale (the only other such stock I can think of is Salesforce.com (NYSE:CR), another entrenched leader but in the frontend application software space, generating tons of cash flow). Based on the record-setting levels of the NASDAQ and investors’ general jitters on tech’s overvaluation, it’s these kinds of stocks that the market will turn to in 2018.

Disclosure: I am/we are long VMW, NTNX.

I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

About this article:ExpandAuthor payment: $35 + $0.01/page view. Authors of PRO articles receive a minimum guaranteed payment of $150-500.Tagged: Investing Ideas, Long Ideas, Technology, Technical & System Software, Editors’ PicksWant to share your opinion on this article? Add a comment.Disagree with this article? Submit your own.To report a factual error in this article, click here

Top 10 Performing Stocks For 2018

In a special episode of Mad Money, Jim Cramer dedicated the entire show to the art and science of technical analysis, picking the best charts from his weekly “Off the Charts” segment and analyzing even closer.

Why study the charts at all? Cramer said it’s because charts are like the footprints at the scene of the crime, clues to what the big money managers are likely thinking. Additionally, charts have a remarkable self-fulfilling nature because so many professionals abide by them religiously.

While Cramer is still a firm believer in fundamental analysis, analyzing how a company is performing and how its sector fits into his larger world view, he said technical analysis can be a useful tool to confirm a trend or disprove a theory.

For example, if the Dow Jones Industrial Average hits a new high, then historically the Dow Transports index needs to also hit a high for the move to be sustainable. If the transports are heading higher, then the move is legitimate.

Top 10 Performing Stocks For 2018: Citigroup Inc.(C)

Advisors’ Opinion:

  • [By John Ballard]

    Partnerships play a crucial role in extending PayPal’s reach to new customers and driving higher engagement. The deal with Visa(NYSE:V) opened the door for partnerships with Mastercard(NYSE:MA), Citigroup(NYSE:C), and Fidelity National Information Services (NYSE:FIS). As a result, more deals will come that will increase PayPal’s relevancy and ubiquity in the mobile payment landscape.

  • [By WWW.THESTREET.COM]

    Bharara’s office also secured major settlements with some of the country’s biggest banks, including Citibank (C) and JPMorgan Chase (JPM) . In 2014, it reached a $1.2 billion agreement with Toyota (TM) over unintended acceleration by its cars.

  • [By Casey Wilson]

    America’s Oldest Companies No. 3: Citigroup Inc. (NYSE: C)

    Citigroup was originally founded in 1812 with $2 million in capital as the “City Bank of New York.” Almost 50 years later, in 1865, it joined the U.S. national banking system and quickly rose to the title of “largest bank in the United States” at the time.

  • [By Ben Levisohn]

    Citigroup (C) has declined0.5% to$58.09 after its earnings topped the Street consensus but its sales fell shortof analyst expectations.

    United Continental Holdings (UAL) has dropped 1.7% to$72.50 despite beating earnings and revenue forecasts.

  • [By Chris Lange]

    The latest quarterly earnings from Citigroup Inc. (NYSE: C) are due onWednesday. The fourth-quarter consensus forecast calls for $1.12 in EPS and $17.3 billion in revenue. Shares were trading at $59.63 on Fridays close, in a 52-week range of $34.52 to $61.63. The consensus price target is $64.31.

Top 10 Performing Stocks For 2018: ThyssenKrupp AG (TYEKF)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    In addition, the company announced that it has agreed to acquire a steel plant in Brazil from ThyssenKrupp (NASDAQOTH:TYEKF) for $1.3 billion. While that plant has had its share of problems in the past, Ternium is getting it for a good value, and it has upside potential. The company paid slightly less than five times EBITDA (earnings before interest, taxes, depreciation, and amortization) for the facility. As the following chart shows, that’s below the value that steel-company stocks trade for these days:

Top 10 Performing Stocks For 2018: The Swatch Group AG (SWGAY)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    That’s good news to the luxury goods sector – from Swiss watches to high fashion and expensive cognac – for which Chinese consumers make up around 30 percent of all global sales. In a note to investors, analysts at investment firm Exane BNP Paribas expects growth to continue to trend upwards during 2017, with Swatch Group (OTCPK:SWGAY), Richemont SA (OTCPK:CFRHF), and Burberry (OTCPK:BURBY) the companies most likely to gain.

  • [By WWW.THESTREET.COM]

    Shares of Swiss watchmaker Swatch Group AG (SWGAY) tumbled 4% mid-afternoon Wednesday as it became apparent the company could lose out to a well-received Apple Inc. (AAPL) Apple Watch 3 released Tuesday.

Top 10 Performing Stocks For 2018: Shopify Inc.(SHOP)

Advisors’ Opinion:

  • [By Brian Withers]

    If investors want to tap into the growing trend of e-commerce and diversify their portfolio beyond Amazon, Shopify (NYSE:SHOP) and Etsy (NASDAQ:ETSY) make the shortlist. Shopify is more a pick-and-shovelplay, as the company hasbuilt a powerful back office platform that essentially enables entrepreneursto run an e-commerce business from their phone. Etsy is a pure play marketplace that focuses on serving the creative entrepreneur. These two companies had similar revenue in 2016, were both started in almost the same year (Etsy 2005, Shopify 2006), and are in the business of helping product-selling entrepreneurs connect to buyers online. Let’s take a deeper dive into these two companies and see which is the better buy.

  • [By WWW.FOOL.COM]

    Shopify(NYSE:SHOP)stock has been on a tear, rocketing up over 180% since the company went public in May of 2015. The company’s business model is pretty simple: Sign up merchants, charge merchants to use its platform, help merchants sell stuff, and take a small percentage from each sale. Then, rinse and repeat at alarger scale with more profitability. Shopify is executing this strategy extremely well, posting strong third quarter 2016 results with record growth in total merchants, sales volume, and revenue.

  • [By Adam Levy]

    Shopify’s(NYSE:SHOP) fourth-quarter earnings results came in above expectations, continuing its flawless streak of earnings beats since going public. The company posted revenue of $130.4 million and breakeven earnings per share. Analysts were expecting a $0.02 loss per share on $121.7 million in sales.

  • [By John Ballard]

    Less than 10% of retail sales in the U.S. take place online, and the worldwide retail market is estimated to be well over $20 trillion.These numbers spell big opportunity for top e-commerce companies like PayPal Holdings (NASDAQ:PYPL) and Shopify (NYSE:SHOP).

  • [By Dan Caplinger, Tim Brugger, and Seth McNew]

    Risk is always a factor for stock market investors, but if you want the top stocks in your portfolio, you have to be bold. To give you some ideas on which stocks to look at, three Motley Fool contributors weighed in on companies they’re familiar with and made a case for why they deserve a closer look. Read on to learn more about Shopify (NYSE:SHOP), Chipotle Mexican Grill (NYSE:CMG), and Universal Display (NASDAQ:OLED) and why they deserve your attention.

Top 10 Performing Stocks For 2018: Citi Trends, Inc.(CTRN)

Advisors’ Opinion:

  • [By Lisa Levin]

    Citi Trends, Inc. (NASDAQ: CTRN) shares shot up 16 percent to $19.38 after the company posted upbeat quarterly earnings.

    Shares of Internap Corp (NASDAQ: INAP) got a boost, shooting up 13 percent to $2.97 on strong quarterly results. Stifel Nicolaus upgraded Internap from Hold to Buy and raised the price target from $2.00 to $5.50.

Top 10 Performing Stocks For 2018: Leucadia National Corporation(LUK)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Then there were financial results released by Jefferies, a unit of Leucadia National (LUK). Its results are often seen as a harbinger for the big U.S. banks, and the results “appear mixed,” according to JMP analyst Devin Ryan. He explains:

  • [By Ben Levisohn]

    We delved into Kraft Heinz’s (KHC) earnings beat, and explained the impact of Leucadia National’s (LUK) investment in National Beef on its earnings.

  • [By Michael Hooper]

    When compared with similar companies, Berkshire Hathaway carries a premium over Markel (NYSE: MKL  ) , valued at 1.15 times book value and a 20 forward P/E ratio; and Leucadia National (NYSE: LUK  ) , valued at 1.10 times book value and a 7.16 trailing P/E.

Top 10 Performing Stocks For 2018: Viacom Inc.(VIA)

Advisors’ Opinion:

  • [By Keith Noonan]

    While 2016 played host to a range of films that underperformed, the biggest flops belonged to Disney (NYSE:DIS), Viacom (NASDAQ:VIA) (NASDAQ:VIAB) and Lions Gate Entertainment (NYSE:LGF.A). Click through the presentation below to get the details on the year’s five biggest film flops and to learn what last year’s movie misfires mean for the companies involved.

  • [By Douglas A. McIntyre]

    The Pillsbury Doughboy is the mascot of the Pillsbury Company, which is owned by General Mills (NYSE: GIS) and J.M. Smucker (NYSE: SJM). The Doughboy was created by Pillsburys advertising agency almost 50 years ago. Pikachu are characters owned by The Pokemon Company International and appear in card games, video games, TV shows, movies and comic books. Founded in 1998, the Japanese company has achieved total games sales of almost 280 million. SpongeBob SquarePants was created for Nickelodeon, which is owned by Viacom (NASDAQ: VIA). The show premiered in 1999 and has spawned movies, video games and theme park rides. Ronald McDonald is a c

Top 10 Performing Stocks For 2018: Nielsen N.V.(NLSN)

Advisors’ Opinion:

  • [By Paul Ausick]

    Nielsen Holdings plc (NYSE: NLSN) dropped about 1.5% Thursday to post a new 52-week low of $40.97 after closing Wednesday at $41.59. The 52-week high is $55.94. Volume of around 5.2 million was about 70% above the daily average of around 3.2 million shares traded. The company had no specific news Thursday.

  • [By Paul Ausick]

    Nielsen Holdings plc (NYSE: NLSN) lost nearly 2.7% Friday to post a new 52-week low of $42.25 after closing Thursday at $43.41. The 52-week high is $55.94. Volume of around 6.7 million was nearly 3 times the daily average of around 2.6 million shares traded. The data research and information company had no specific news Friday.

Top 10 Performing Stocks For 2018: Gartner, Inc.(IT)

Advisors’ Opinion:

  • [By Lisa Levin]

    CEB Inc. (NYSE: CEB) shares were also up, gaining 21 percent to $74.90 after Gartner Inc (NYSE: IT) announced plans to acquire the company for $2.6 billion in cash and stock.

Top 10 Performing Stocks For 2018: Warren Resources Inc.(WRES)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Warren Resources, Inc. (NASDAQ: WRES) were down 31 percent to $0.0656. Warren Resources filed for Chapter 11 bankruptcy.

    Gogo Inc (NASDAQ: GOGO) was down, falling around 15 percent to $9.40 after the company announced it has reached an agreement with American Airlines Group Inc (NASDAQ: AAL) to “continue to provide service on a meaningful portion of the American fleet currently served by Gogo.” Investors heavily sold off the stock as the company’s announcement implies it lost some orders to its main competitor, ViaSat, Inc. (NASDAQ: VSAT).

Top 5 Blue Chip Stocks To Own For 2018

Investors can add all sorts of investments to an IRA, but many financial advisors will suggest sticking with conservative dividend stocks. The reason is simple — blue chip income generators generally bounce back from big market crashes, and the compounding effect of reinvested dividends can deliver massive returns over several decades.

At first glance, tobacco giant Altria (NYSE:MO) seems like a great stock for an IRA. Its flagship Marlboro brand dominates the U.S. market, it pays a hefty forward dividend yield of 3.4%, and it’s hiked that dividend every year since it spun off itsoverseas business as Philip Morris International (NYSE:PM) in 2008. But if you gaze further into Altria’s future, you’ll realize that it’s not a great long-term pick for your IRA at all.

Image source: Getty Images.

Why Altria seems like a good IRA stock

Altria shares have rallied 20% over the past 12 months, outperforming Philip Morris’ 15% rally but slightly underperforming the S&P 500’s 25% gain. Much of that growth can be attributed to two factors — a flight to high-yielding dividend stocks in a low interest rate environment and Altria’s purely domestic business insulating it from the currency headwinds which gobbled up Philip Morris’ overseas gains.

Top 5 Blue Chip Stocks To Own For 2018: Gartner, Inc.(IT)

Advisors’ Opinion:

  • [By Lisa Levin]

    CEB Inc. (NYSE: CEB) shares were also up, gaining 21 percent to $74.90 after Gartner Inc (NYSE: IT) announced plans to acquire the company for $2.6 billion in cash and stock.

Top 5 Blue Chip Stocks To Own For 2018: Nam Tai Electronics Inc.(NTE)

Advisors’ Opinion:

  • [By Roberto Pedone]

    Another stock that’s starting to move within range of triggering a big breakout trade is Nam Tai Electronics (NTE), which is an electronics manufacturing and design services provider to a select group of the world’s leading OEMs of telecommunications and consumer electronic products. This stock has been destroyed by the sellers so far in 2013, with shares off sharply by 41%.

    If you look at the chart for Nam Tai Electronics, you’ll notice that this stock has been uptrending for the last month and change, with shares moving higher from its low of $6.05 to its recent high of $8.38 a share. During that uptrend, shares of NTE have been making mostly higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of NTE within range of triggering a big breakout trade.

    Traders should now look for long-biased trades in NTE if it manages to break out above some key near-term overhead resistance levels at $8.38 to $8.79 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 647,483 shares. If that breakout triggers soon, then NTE will set up to re-fill some of its previous gap down zone from April that started near $11.50 a share. If this stock gets into that gap with volume, then the upside is tremendous and we could easily see NTE hit $11 to $12 a share.

    Traders can look to buy NTE off any weakness to anticipate that breakout and simply use a stop that sits right below its 50-day at $7.42 a share, or below more key support at $7.22 a share. One can also buy NTE off strength once it takes out that breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

Top 5 Blue Chip Stocks To Own For 2018: Navigant Consulting, Inc.(NCI)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Navigant Consulting, Inc. (NYSE: NCI) were down 14 percent to $17.02 after the company posted downbeat quarterly results.

    Hertz Global Holdings, Inc (NYSE: HTZ) was down, falling around 18 percent to $14.24. Barclays downgraded Hertz from Equal-Weight to Underweight.

Top 5 Blue Chip Stocks To Own For 2018: ePlus Inc.(PLUS)

Advisors’ Opinion:

  • [By Monica Gerson]

    ePlus Inc. (NASDAQ: PLUS) is estimated to post its quarterly earnings at $1.21 per share on revenue of $284.62 million.

    Tilly’s Inc (NYSE: TLYS) is expected to post a quarterly loss at $0.07 per share on revenue of $119.93 million.

Top 5 Blue Chip Stocks To Own For 2018: Aurora Cannabis Inc. (ACBFF)

Advisors’ Opinion:

  • [By Javier Hasse]

    Also quite recently, Benzinga asked Alan Brochstein, founding partner at New Cannabis Ventures and founder at 420 Investor, about plays in the marijuana industry against such an uncertain backdrop. The expert mentioned a few Canadian Licensed Producers, including AURORA CANNABIS IN COM NPV (OTC: ACBFF), APHRIA INC NPV (OTC: APHQF), METTRUM HEALTH COR COM NPV (OTC: MQTRF), ORGANIGRAM HLDGS I COM NPV (OTC: OGRMF), SUPREME PHARMACEUT COM NPV (OTC: SPRWF) and CANOPY GROWTH CORP COM NPV (OTC: TWMJF), as well as “the only” biotech stock in the space, GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH).

  • [By Sean Williams]

    This rapid growth in legal pot has create quite the demand for marijuana stocks. The seven largest marijuana stocks by market cap have all put on a show over the past couple of years. Here are those seven “green giants” listed with their market caps as of March 17, 2017, along with their trailing one-year total returns.

    GW Pharmaceuticals (NASDAQ:GWPH): $3.0 billion, up 64% Canopy Growth Corp. (NASDAQOTH:TWMJF): $904 million, up 259% Aphria (NASDAQOTH:APHQF) $440 million, up 381% Aurora Cannabis (NASDAQOTH:ACBFF): $482 million, up 299% AXIM Biotechnologies (NASDAQOTH:AXIM): $562 million, up 1,720% Corbus Pharmaceuticals (NASDAQ:CRBP): $450 million, up 431% Medical Marijuana (NASDAQOTH:MJNA): $221 million, up 254%

    As you can see, these are some hefty valuations — and some exceptionally strong moves higher on the heels of marijuana’s expansion. With the exception of GW Pharmaceuticals, every one of the largest marijuana stocks has at least tripled in value over the trailing 12 months, with cannabinoid-based drug developer AXIM Biotechnologies skyrocketing more than 1,700%!

  • [By SEEKINGALPHA.COM]

    This article is for those who are hopeful of the long-term view and want to get in ahead of time. This article will compare the three front-runners of the Canadian cannabis industry, Canopy Growth Corp. (OTCPK:TWMJF), Aphria (NYSE:APH), and Aurora (OTCQX:ACBFF). Although these companies will soon have to prove themselves in a new environment, there is plenty to study right now. We will be comparing revenue growth, production capacity, valuations, and then making financial projections. The result will be a recommendation of Aurora followed by Canopy. Again this article is meant to compare competitors. The industry has the potential to be a 22.6B industry but the thesis for investing in Canadian cannabis is a separate topic and I encourage you to consider the risks.

  • [By Javier Hasse]

    While biotechs like GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH) and Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE) only lost 0.45 percent and 0.36 percent respectively, other companies experienced a large tumble. CANOPY GROWTH CORP COM NPV (OTC: TWMJF) lost 4.71 percent, AURORA CANNABIS IN COM NPV (OTC: ACBFF) slipped 2.93 percent, APHRIA INC COM NPV (OTC: APHQF) dropped 1.01 percent, and MassRoots Inc (OTC: MSRT) plummeted an astounding 9.00 percent.

  • [By Keith Speights]

    As increasingly more marijuana growers entered the market and more states allowed residents to legally grow marijuana, cannabis prices dropped throughout 2016. Wholesale marijuana prices late in the year were roughly half the levels of 12 months earlier. Will this trend continue — and possibly hurt leading marijuana stocks including Aphria (NASDAQOTH:APHQF),Aurora Cannabis (NASDAQOTH:ACBFF), Medical Marijuana,Inc.(NASDAQOTH:MJNA), and even GW Pharmaceuticals (NASDAQ:GWPH) in the process?

Top Low Price Stocks To Own Right Now

Dollar General (DG) marked its 27th consecutive year of same-store sales growth in fiscal 2016. It followed this milestone up with a beat on both the top and bottom lines during its first quarter of 2017, with comps once again growing – but by only about 0.7%. As I was sifting through the retail carnage, Dollar General was one of the companies that stood out as above average, so I decided to take a closer look with this article.

The business

The company’s primary niche seems to come from its low cost operating structure. The majority of its stores are rural, with roughly 70% of them located in towns of 20,000 people or less. It constantly seeks ways to reduce (or at least control) costs that won’t affect the shopping experience for its customers, many of whom are primarily in a lower income bracket. This is exhibited by its low prices, where 80% of its stock-keeping units are set at $5 or less.

Source: 2016 10-K

Top Low Price Stocks To Own Right Now: On Assignment Inc.(ASGN)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Thursday, our Under the Radar Moversnewslettersuggested suggested small cap employment services stockOn Assignment, Inc (NYSE: ASGN) as a short trade thats already turned profitable for us:

Top Low Price Stocks To Own Right Now: Quality Systems, Inc.(QSII)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Tuesday, our Elite Opportunity Pronewsletter suggested small cap health care technology stock Quality Systems, Inc (NASDAQ: QSII) as a short-term trading opportunity after popping sharply on news:

Top Low Price Stocks To Own Right Now: Flagstar Bancorp, Inc.(FBC)

Advisors’ Opinion:

  • [By Dustin Blitchok]

    When Alessandro DiNello was named CEO of Flagstar Bancorp Inc (NYSE: FBC) in 2013, the bank was on a financial precipice.

    The bank’s business was almost entirely mortgages. As the industry unraveled nationally, Flagstar accepted $267 million in TARP money in 2009 — as well as private equity financing — to maintain solvency.

Top Low Price Stocks To Own Right Now: Gartner, Inc.(IT)

Advisors’ Opinion:

  • [By Lisa Levin]

    CEB Inc. (NYSE: CEB) shares were also up, gaining 21 percent to $74.90 after Gartner Inc (NYSE: IT) announced plans to acquire the company for $2.6 billion in cash and stock.

Top Low Price Stocks To Own Right Now: Open Text Corporation(OTEX)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    One split announcement came from OpenText Inc. (OTEX) — a stock we had already added to our portfolio back in July, 2014; it has since done very well.

Top Low Price Stocks To Own Right Now: Proteon Therapeutics, Inc.(PRTO)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Proteon Therapeutics Inc (NASDAQ: PRTO) got a boost, shooting up 31 percent to $1.70 after the company disclosed that it has received the FDA Breakthrough Therapy designation for Vonapanitase. Proteon Therapeutics posted a narrower-than-expected quarterly loss.

day trading software

This article is reprinted by permission from NextAvenue.org.

If you are like most people, when you hear the words estate planning, you probably think of writing a will, to explain who will get what you own when you die. The problem is, a will has little or nothing to do withyou. Its all about planning for someone else. In reality, estate planning is about much more than writing a will; its also about taking care ofyouwhile you are alive, should you become incapacitated and unable to make your own decisions.

day trading software: MannKind Corporation(MNKD)

Advisors’ Opinion:

  • [By James E. Brumley]

    When most investors think of diabetes stocks, names like Novo Nordisk A/S (ADR) (NYSE:NVO) and MannKind Corporation (NASDAQ:MNKD) come to mind. And well they should. Novo Nordisk is the biggest insulin company in the world, and while MannKind is relatively small, it’s a name that turns heads simply because it came up with an inhalable insulin that – after a slow start – is getting a little traction.

    In both cases though, the paradigm is the same one that was first used decades ago. That is, if a person isn’t making their own insulin, then it must be introduced externally. What if instead a diabetic’s glucose levels could be controlled by turning on the cells in their body responsible for processing that sugar? That’s the approach Cell MedX Corp (OTCMKTS:CMXC) is taking, using a relatively new but very compelling science.

    While chemical-based manufactured pharmaceuticals were largely the core of healthcare for well over the past century, it’s become clear that our bodies – right down to our cells – are also electrical in nature. Not only do they produce it, they need it to function properly. The FDA has even recently approved a therapeutic device that delivers mild electrical currents to and through an individual’s body as a means of treating pain. This “electromedicine” has also shown a certain degree of efficacy as a treatment for several illnesses, including cancer. Specifically, electrical currents have been demonstrated to force pleomorphic cancer microbes into hibernation, essentially making a cancerous cell a normal, healthy cell again. So, using an electrical current as a means of therapy for diabetics isn’t far-fetched at all. Indeed, it’s quite brilliant.

    As for how Cell MedX is using the idea, it’s actually quite simple. The device is called an eBalance. At first glance it just looks like another ordinary tablet computer. A closer inspection of the e-Balance device, however, makes it clear that it’s not just another tablet. It’

  • [By Sean Williams]

    Last summer, my mind was fully set on short-selling shares (i.e., betting they go down) of drugmaker MannKind (NASDAQ:MNKD). My investment thesis was pretty straightforward: MannKind was eventually going to seek bankruptcy protection.

  • [By Peter Graham]

    Small cap diabetes stock MannKind Corporation (NASDAQ: MNKD) reportedQ1 2017 earnings after the Thursday market close.The Companysnovel rapid-acting inhaled insulin therapy Afrezza has generally been a disappointment for investors with the stock havingelevated short interest of 38.86% according to Highshortinterest.com.

  • [By Lisa Levin]

    MannKind Corporation (NASDAQ: MNKD) shares were also up, gaining 24 percent to $6.59. H.C. Wainwright initiated coverage on MannKind with a Buy rating and a $7.00 price target.

  • [By WWW.MONEYSHOW.COM]

    MannKind Corp. (MNKD) has developed a drug, Afrezza, which is a new form of inhalable insulin that is proving to have many benefits over existing mealtime insulins for diabetics.  

  • [By Peter Graham]

    The Q4 2016 earnings report for troubled small cap diabetes stock MannKind Corporation (NASDAQ: MNKD) is scheduled for after the market closes Thursday (March 16th). So far,MannKind Corporations novel rapid-acting inhaled insulin therapy Afrezza has been a disappointment for investors; and if that doesnt start to change, theMNKD could soon run out of money. For that reason, the Company has elevated short interest of 36.43% according to Highshortinterest.com.

day trading software: Towerstream Corporation(TWER)

Advisors’ Opinion:

  • [By Lisa Levin]

    Towerstream Corporation (NASDAQ: TWER) shares were also up, gaining 9 percent to $3.49. Towerstream is scheduled to report Q2 financial results on August 9, 2016.

day trading software: Nord Anglia Education, Inc.(NORD)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Monday, our Under the Radar Moversnewsletter suggested going long on small cap international school stock Nord Anglia Education Inc (NYSE: NORD):

  • [By Lisa Levin]

    Nord Anglia Education Inc (NASDAQ: NORD) shares shot up 19 percent to $32.83 after the company agreed to be acquired for $32.50 per share in cash.

day trading software: CIRCOR International, Inc.(CIR)

Advisors’ Opinion:

  • [By Lisa Levin]

    CIRCOR International, Inc. (NYSE: CIR) was down, falling around 15 percent to $60.91. CIRCOR reported Q4 adjusted earnings of $0.48 per share on revenue of $158 million. Stifel Nicolaus downgraded Circor from Buy to Hold.

day trading software: Gartner, Inc.(IT)

Advisors’ Opinion:

  • [By Lisa Levin]

    CEB Inc. (NYSE: CEB) shares were also up, gaining 21 percent to $74.90 after Gartner Inc (NYSE: IT) announced plans to acquire the company for $2.6 billion in cash and stock.

day trading software: Signet Jewelers Limited(SIG)

Advisors’ Opinion:

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Thursday was Signet Jewelers Limited (NYSE: SIG), which rose roughly 9% to $52.52. The stocks 52-week range is $46.09 to $101.46. Volume was nearly 5 million on the day compared to the average of 1.8 million.

  • [By Peter Graham]

    A long term performance chart shows shares of Tiffany & Co and small cap Blue Nile Inc (NASDAQ: NILE) nowback in positive territory and trending up while Signet Jewelers Ltd (NYSE: SIG) has outperformedbut that outperformancestarted falling off late last year:

  • [By WWW.THESTREET.COM]

    Earnings of note in the coming week include Analogic (ALOG) and Ascena Retail (ASNA) on Monday; Bojangles (BOJA) , H&R Block (HRB) , and Dick’s Sporting Goods (DKS) , Michaels (MIK) , and Urban Outfitters (URBN) on Tuesday; Ciena (CIEN) , Bankrate (RATE) , Express (EXPR) , Vera Bradley (VRA) , and Bob Evans Farms (BOBE) on Wednesday; El Pollo Loco (LOCO) , Hugo Boss (BOSSY) , Party City (PRTY) , Signet Jewelers (SIG) , and Verifone Systems (PAY) on Thursday; and Kirkland’s (KIRK) , and Vail Resorts (MTN) on Friday.

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Thursday was Signet Jewelers Limited (NYSE: SIG) which jumped 8.8% to $70.06. The gain was following news that the company had a solid earnings report. The stocks 52-week range is $62.10 to $125.45. Volume was 7.48 million which is well above the daily average of around 1.69 million shares.